MDxHealth FY25 net loss narrows 12% to $33.5 million; revenue rises 20% to $107.9 million

MDxHealth S.A.

MDXH

0.00

MDxHealth posted fiscal-year 2025 net loss of USD 33.5 million, narrowing 12%.
Revenue climbed 20% to USD 107.9 million.
Operating loss shrank 42% to USD 14.4 million.
Gross margin widened 3.3 percentage points to 64.5% due to economies of scale from improved fixed-cost absorption.
Management expects net losses and significant cash outflows for at least the next 12 months, despite estimating cash and anticipated product cash flows will cover requirements for at least 12 months from the annual report date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MDxHealth SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-039540), on April 03, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.